特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
213101

アルコール依存症:パイプライン分析

Alcohol Addiction - Pipeline Review, H2 2020

出版日: | 発行: Global Markets Direct | ページ情報: 英文 180 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
アルコール依存症:パイプライン分析
出版日: 2020年07月31日
発行: Global Markets Direct
ページ情報: 英文 180 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アルコール依存症(アルコール乱用)とは、アルコールへの心理的・肉体的な依存状態のことを指します。主な症状として、社会的活動への参加の低下やうつ病、不穏状態、飲酒の自制・節制ができない状態、暴力行動などが挙げられます。

当レポートでは、世界各国でのアルコール依存症(アルコール中毒)治療用のパイプライン製品の開発状況について分析し、製品開発・上市の最新動向や、治験の各段階にある製品の一覧、主要企業のプロファイル、主な薬剤の概要、最新の業界動向などの情報をお届けします。

目次

イントロダクション

  • 分析範囲

アルコール依存症の概要

治療薬の開発

  • アルコール依存症向けパイプライン製品:概要
  • アルコール依存症向けパイプライン製品:比較分析

各企業で開発中のアルコール依存症治療薬

大学/研究機関で研究中のアルコール依存症治療薬

パイプライン製品の概略

  • 後期段階の製品
  • 治験段階の製品
  • 初期段階の製品

アルコール依存症治療薬:開発中の製品の一覧(企業別)

アルコール依存症治療薬:研究中の製品の一覧(大学/研究機関別)

アルコール依存症治療薬の開発に従事している企業

アルコール依存症:治療薬の評価

  • 単剤治療薬の場合
  • 併用治療薬の場合
  • 標的別
  • 作用機序別
  • 投与方法別
  • 分子の種類別

薬剤のプロファイル

アルコール依存症治療薬:パイプライン製品の最新動向

アルコール依存症治療薬:開発が休止状態の製品

アルコール依存症治療薬:開発が中止された製品

アルコール依存症関連製品の開発のマイルストーン

  • 注目すべき最新動向・プレスリリース

付録

図表一覧

図表

List of Tables

List of Tables

  • Number of Products under Development for Alcohol Addiction, H2 2020
  • Number of Products under Development by Companies, H2 2020
  • Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
  • Number of Products under Development by Universities/Institutes, H2 2020
  • Products under Development by Companies, H2 2020
  • Products under Development by Companies, H2 2020 (Contd..1), H2 2020
  • Products under Development by Companies, H2 2020 (Contd..2), H2 2020
  • Products under Development by Universities/Institutes, H2 2020
  • Number of Products by Stage and Target, H2 2020
  • Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
  • Number of Products by Stage and Mechanism of Action, H2 2020
  • Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020
  • Number of Products by Stage and Route of Administration, H2 2020
  • Number of Products by Stage and Molecule Type, H2 2020
  • Alcohol Addiction - Pipeline by Adial Pharmaceuticals Inc, H2 2020
  • Alcohol Addiction - Pipeline by Amygdala Neurosciences Inc, H2 2020
  • Alcohol Addiction - Pipeline by Aptinyx Inc, H2 2020
  • Alcohol Addiction - Pipeline by Assuage Pharmaceuticals Inc, H2 2020
  • Alcohol Addiction - Pipeline by Astraea Therapeutics LLC, H2 2020
  • Alcohol Addiction - Pipeline by AstraZeneca Plc, H2 2020
  • Alcohol Addiction - Pipeline by Avicanna Inc, H2 2020
  • Alcohol Addiction - Pipeline by BioCorRx Inc, H2 2020
  • Alcohol Addiction - Pipeline by Bioprojet SCR, H2 2020
  • Alcohol Addiction - Pipeline by Chronos Therapeutics Ltd, H2 2020
  • Alcohol Addiction - Pipeline by Colorado Research Partners LLC, H2 2020
  • Alcohol Addiction - Pipeline by Confluence Pharmaceuticals LLC, H2 2020
  • Alcohol Addiction - Pipeline by Corcept Therapeutics Inc, H2 2020
  • Alcohol Addiction - Pipeline by Curemark LLC, H2 2020
  • Alcohol Addiction - Pipeline by Dicerna Pharmaceuticals Inc, H2 2020
  • Alcohol Addiction - Pipeline by Eli Lilly and Co, H2 2020
  • Alcohol Addiction - Pipeline by Kinnov Therapeutics SAS, H2 2020
  • Alcohol Addiction - Pipeline by Kinoxis Therapeutics Pty Ltd, H2 2020
  • Alcohol Addiction - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2020
  • Alcohol Addiction - Pipeline by Laboratorio Farmaceutico CT Srl, H2 2020
  • Alcohol Addiction - Pipeline by Lohocla Research Corp, H2 2020
  • Alcohol Addiction - Pipeline by Mapreg SAS, H2 2020
  • Alcohol Addiction - Pipeline by Mind Medicine Inc, H2 2020
  • Alcohol Addiction - Pipeline by Montisera Ltd, H2 2020
  • Alcohol Addiction - Pipeline by Naprogenix Inc, H2 2020
  • Alcohol Addiction - Pipeline by Omeros Corp, H2 2020
  • Alcohol Addiction - Pipeline by Opiant Pharmaceuticals Inc, H2 2020
  • Alcohol Addiction - Pipeline by Orphomed Inc, H2 2020
  • Alcohol Addiction - Pipeline by Osmotica Pharmaceutical Corp, H2 2020
  • Alcohol Addiction - Pipeline by Palisades Therapeutics, H2 2020
  • Alcohol Addiction - Pipeline by Pfizer Inc, H2 2020
  • Alcohol Addiction - Pipeline by SK Biopharmaceuticals Co Ltd, H2 2020
  • Alcohol Addiction - Pipeline by Sosei Heptares, H2 2020
  • Alcohol Addiction - Pipeline by South Plains Biotechnology Inc, H2 2020
  • Alcohol Addiction - Pipeline by Syntropharma Ltd, H2 2020
  • Alcohol Addiction - Pipeline by Tonix Pharmaceuticals Holding Corp, H2 2020
  • Alcohol Addiction - Pipeline by VM Discovery Inc, H2 2020
  • Alcohol Addiction - Pipeline by Zynerba Pharmaceuticals Inc, H2 2020
  • Alcohol Addiction - Dormant Projects, H2 2020
  • Alcohol Addiction - Dormant Projects, H2 2020 (Contd..1), H2 2020
  • Alcohol Addiction - Dormant Projects, H2 2020 (Contd..2), H2 2020
  • Alcohol Addiction - Discontinued Products, H2 2020

List of Figures

List of Figures

  • Number of Products under Development for Alcohol Addiction, H2 2020
  • Number of Products under Development by Companies, H2 2020
  • Number of Products by Top 10 Targets, H2 2020
  • Number of Products by Stage and Top 10 Targets, H2 2020
  • Number of Products by Top 10 Mechanism of Actions, H2 2020
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
  • Number of Products by Routes of Administration, H2 2020
  • Number of Products by Stage and Routes of Administration, H2 2020
  • Number of Products by Molecule Types, H2 2020
  • Number of Products by Stage and Molecule Types, H2 2020
目次
Product Code: GMDHC12359IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcohol Addiction - Pipeline Review, H2 2020, provides an overview of the Alcohol Addiction (Central Nervous System) pipeline landscape.

Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking and violent behavior. Risk factors include age, family history and depression and other mental health problems.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alcohol Addiction - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Alcohol Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 1, 10, 4, 21, 3 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.

Alcohol Addiction (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Alcohol Addiction (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Alcohol Addiction (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Alcohol Addiction (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Alcohol Addiction (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Alcohol Addiction (Central Nervous System)

Reasons to Buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Alcohol Addiction (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Alcohol Addiction (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

  • Introduction
  • Alcohol Addiction - Overview
  • Alcohol Addiction - Therapeutics Development
  • Alcohol Addiction - Therapeutics Assessment
  • Alcohol Addiction - Companies Involved in Therapeutics Development
  • Alcohol Addiction - Drug Profiles
  • Alcohol Addiction - Dormant Projects
  • Alcohol Addiction - Discontinued Products
  • Alcohol Addiction - Product Development Milestones
  • Appendix
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.